Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Migraine

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    June 2021
  1. BURCH R, Rayhill M
    Acute Treatment for Migraine: Contemporary Treatments and Future Directions.
    JAMA. 2021;325:2346-2347.
    PubMed    


  2. WINNER PK, McAllister P, Chakhava G, Ailani J, et al
    Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
    JAMA. 2021;325:2348-2356.
    PubMed     Abstract available


  3. VANDERPLUYM JH, Halker Singh RB, Urtecho M, Morrow AS, et al
    Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
    JAMA. 2021;325:2357-2369.
    PubMed     Abstract available


    May 2021
  4. ROBBINS MS
    Diagnosis and Management of Headache: A Review.
    JAMA. 2021;325:1874-1885.
    PubMed     Abstract available


    February 2021
  5. SLOMSKI A
    Oral Rimegepant Safe, Effective for Migraine Prevention.
    JAMA. 2021;325:713.
    PubMed    


    September 2020

  6. Rimegepant (Nurtec ODT) for Acute Treatment of Migraine.
    JAMA. 2020;324:890-891.
    PubMed    


    June 2020
  7. KURTH T, Rist PM, Ridker PM, Kotler G, et al
    Association of Migraine With Aura and Other Risk Factors With Incident Cardiovascular Disease in Women.
    JAMA. 2020;323:2281-2289.
    PubMed     Abstract available


    February 2020
  8. VOELKER R
    New Migraine Drug Gains Approval.
    JAMA. 2020;323:408.
    PubMed    


    November 2019
  9. LIPTON RB, Dodick DW, Ailani J, Lu K, et al
    Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.
    JAMA. 2019;322:1887-1898.
    PubMed     Abstract available


    March 2019
  10. SENN SJ, Lewis RJ
    Treatment Effects in Multicenter Randomized Clinical Trials.
    JAMA. 2019;321:1211-1212.
    PubMed    


    November 2018
  11. VOELKER R
    Preventive Migraine Drug Approved.
    JAMA. 2018;320:1746.
    PubMed    


    May 2018
  12. DODICK DW, Silberstein SD, Bigal ME, Yeung PP, et al
    Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
    JAMA. 2018;319:1999-2008.
    PubMed     Abstract available


  13. LODER EW, Robbins MS
    Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea.
    JAMA. 2018;319:1985-1987.
    PubMed    


    December 2017
  14. SLOMSKI A
    Prochlorperazine Superior to Hydromorphone for Migraine.
    JAMA. 2017;318:2419.
    PubMed    


    June 2017

  15. Prevention of Migraine.
    JAMA. 2017;317:2230-2231.
    PubMed    


    April 2017
  16. SLOMSKI A
    Acupuncture May Be Effective for Long-term Migraine Prophylaxis.
    JAMA. 2017;317:1615.
    PubMed    


    December 2016
  17. SLOMSKI A
    Still No Migraine Relief for Kids.
    JAMA. 2016;316:2589.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: